Investors / United States / Hatteras Venture Partners
Hatteras Venture Partners
Venture capital · Durham, NC, United States · North America
Hatteras Venture Partners is a venture capital firm that invests in healthcare companies across biotech, MedTech, and HealthTech. It partners with founders from initial investment through liquidity and assists portfolio companies with team recruitment, portfolio strategy, business development, and regulatory and clinical planning.
Invests inHealthcare & Biotech
In its own wordshealthcarebiotechmedtechhealthtechearly-stagelife-sciences
Your fit with Hatteras Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsHatteras Venture Partners lists 61 checked portfolio companies on its own site and is named in 6 funding rounds, 2 of them as lead. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (92%), Education (3%) and AI & Machine Learning (3%). 95% of its companies are based in United States. It invests most often alongside Mountain Group Partners, NEA and Lumira Ventures.
Counts come from funding rounds that name Hatteras Venture Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Hatteras Venture Partners' whole history. Rounds on record name 6 companies; its own site lists 61. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 17% |
| Series A | 17% |
| Series B | 50% |
| Growth | 17% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 5 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 88th | 61 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 57th | 17% of entries at pre-seed or seed |
| Evidence | 72th | 8% of companies confirmed by a round |
| Sector focus | 96th | 92% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Mountain Group Partners | 6 |
| NEA | 6 |
| Lumira Ventures | 5 |
| Solasta Ventures | 5 |
| Arboretum Ventures | 4 |
| Excelerate Health Ventures | 4 |
| Boston Millennia Partners | 3 |
| Broadview Ventures | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5997%
- No longer answers00%
- Points to another company23%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 92% | 15% |
| Education | 3% | 7% |
| AI & Machine Learning | 3% | 18% |
| E-commerce & Marketplaces | 2% | 6% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Mountain Group Partners
Compare Hatteras Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Hatteras Venture Partners| Date | Company | Stage |
|---|---|---|
| 2 Nov 2026 | Series A Led | |
| 16 Jul 2026 | Series B | |
| 14 Jul 2026 | Series C+ | |
| 23 Jun 2026 | Seed | |
| 14 May 2026 | Series B Led | |
| 4 Sept 2025 | Series B |
Round details for Hatteras Venture Partners
Amounts, full round histories and every co-investor in Hatteras Venture Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
61 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company develops and sells a hand-operated rapid infuser for delivering blood or fluids to critically ill patients | Healthcare & Biotech | Jul 2026Series C+ | Page + round | |
| Aer Therapeutics develops a therapy to liquify mucus plugs in the lungs to improve lung health | Healthcare & Biotech | Portfolio page | ||
| Altis Biosystems develops human intestinal models for drug discovery and research. | Healthcare & Biotech | Portfolio page | ||
| AN2 Therapeutics develops boron-based medicines for various diseases, including polycythemia vera, Chagas disease, and certain types of cancer. | Healthcare & Biotech | Portfolio page | ||
| AtaCor Medical designs novel extravascular defibrillation leads and deployment systems for cardiac rhythm management | Healthcare & Biotech | Portfolio page | ||
| Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. | Healthcare & Biotech | Portfolio page | ||
| Avivomed is developing neuromodulation therapies for patients suffering from obstructive sleep apnea | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Backr brings together human coaches, an AI-native platform, purpose-built tools, data on schools, majors and paths, scholarships, jobs and internships, learning content, and curriculum to help students achieve their college and career aspirations. | EducationEducation | Portfolio page | ||
| BekHealth connects sponsors and research sites with a network of patients and sites to accelerate clinical trial recruitment and generate real-world data | Healthcare & Biotech | Portfolio page | ||
| The company is conducting a clinical study to test a new treatment for bowel urgency symptoms in adults with ulcerative colitis. | Healthcare & Biotech | Sept 2025Series B | Page + round | |
| Portfolio page | ||||
| Cardiosense develops a heart failure monitoring solution to noninvasively determine Pulmonary Capillary Wedge Pressure at the point of care. | Healthcare & Biotech | Portfolio page | ||
| Clearside Biomedical, Inc. is an intellectual property holding, investment, and commercialization company with a portfolio of intellectual property covering its proprietary ocular drug-delivery platform and microinjector technology. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Code Biotherapeutics is developing precision genetic medicines to treat life-threatening diseases. | Healthcare & Biotech | Portfolio page | ||
| Contego Medical develops and manufactures medical devices for carotid and peripheral vascular procedures. | Healthcare & Biotech | Portfolio page | ||
| CREATE Medicines is pioneering multi-immune programming with its versatile in vivo CAR platform. | Healthcare & Biotech | May 2026Series B | Page + round | |
| Curoverse helps you manage, process, analyze, and share massive biomedical data sets for everything from genomics to imaging. | Healthcare & Biotech | Portfolio page | ||
| CVRx develops and implants a device to treat heart failure | Healthcare & Biotech | Portfolio page |
About this data
site last read 10 Nov 2026- Site
- hatterasvp.com
- Last read
- 10 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 4 Sept 2025
- Companies checked
- 61
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Hatteras Venture Partners' profile as data
Pull Hatteras Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/hatterasvp.com
# also
GET /v1/firms/hatterasvp.com/portfolio
GET /v1/firms/hatterasvp.com/coinvestors
GET /v1/firms/hatterasvp.com/news